Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 104642

In scope icon M 6 E
QID 104642 (Type "104642" in App Search)
A 76-year-old male presents to his primary care physician for symptoms of fatigue. As part of the workup, a serum protein electrophoresis (SPEP) is ordered, which finds an elevated M protein. Which of the following tests would be the LEAST useful in distinguishing between the two conditions associated with this laboratory abnormality?

Skull radiograph

5%

1/21

Bone marrow biopsy

10%

2/21

Serum creatinine

0%

0/21

Serum calcium

0%

0/21

Serum TSH

81%

17/21

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

The patient in this vignette has an elevated M protein, which cannot distinguish between multiple myeloma (MM) and monoclonal gammopathy of undetermined significance (MGUS). Multiple myeloma does not cause altered thyroid function.

Multiple myeloma (MM) is cancer of monoclonal plasma cells, which produces large amounts of IgG (55%) or IgA (25%). MM is the most common primary tumor arising within bone in the elderly. If there are increased gamma globulins on serum electrophoresis, but no symptoms of multiple myeloma are present (including bone lesions, reduced renal function, and anemia), this condition is called monoclonal gammopathy of undetermined significance (MGUS). Of note, there is often a decreased humoral immunity in patients with MM as plasma cells become unable to generate neutralizing antibodies.

O'Connell et al. review the use of serum protein electrophoresis (SPEP) in diagnosis of serum protein disorders. Mechanistically, electrophoresis separates proteins based on their physical properties, including charge and size. A homogeneous peak in a focal region of the gamma-globulin zone indicates a monoclonal gammopathy, which may including MM, Waldenstrom's macroglobulinemia, or MGUS. This is in contrast to polyclonal gammopathies (more than one peak on SPEP), which may be caused by any reactive or inflammatory process.

Dispenzieri et al. discuss smoldering multiple myeloma (SMM), an intermediate condition between MGUS and active MM in which some symptoms are present but the patient does not have the classic MM presentation. The majority of studies involving MM treatment given to patients with SMM showed no improved overall survival with therapy as compared to observation. This study concludes that in cases with extreme bone marrow plasmacytosis, extremely abnormal serum immunoglobulin free light chain ratio, and multiple bone lesions detected only by modern imaging, these patients should be treated as having MM.

Illustration A shows an example SPEP seen with MM and MGUS. Note the circled peak in gamma globulins.

Incorrect Answers:
Answer 1: Skull radiograph may reveal lytic bone lesions which are seen in MM but not MGUS.
Answer 2: Bone marrow biopsy may reveal plasma cell cytosis which is seen in MM but not MGUS.
Answer 3: Serum creatinine may reveal signs of renal injury which is seen in MM but not MGUS.
Answer 4: Serum calcium may reveal signs of hypercalcemia which is seen in MM but not MGUS.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

3.1

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(7)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options